What analysts say:
- Buy, sell, or hold?: Half of analysts think investors should stand pat on Meredith while the remaining half rate the stock as a buy. Analysts don't like Meredith as much as competitor Scholastic overall. Two out of three analysts rate Scholastic a buy compared to three out of six for Meredith. Wall Street has warmed to the stock over the past three months, with analysts increasing their endorsement from hold to moderate buy.
- Revenue forecasts: On average, analysts predict $326.5 million in revenue this quarter. That would represent a decline of 5.2% from the year-ago quarter.
- Wall Street earnings expectations: The average analyst estimate is earnings of $0.46 per share. Estimates range from $0.45 to $0.47.
What our community says:
CAPS All-Stars are solidly behind the stock, with 88.5% awarding it an outperform rating. The community at large backs the All-Stars, with 81.5% giving it a rating of outperform. Fools are bullish on Meredith, though the message boards have been quiet lately with only 54 posts in the past 30 days. Despite the majority sentiment in favor of Meredith, the stock has a middling CAPS rating of three out of five stars.
Meredith's profit has risen year over year by an average of 34.4% over the past five quarters. Revenue has fallen in the past two quarters. The company's gross margin shrank by 2.1 percentage points in the last quarter. Revenue fell 4.6% while cost of sales rose 0.7% to $137.2 million from a year earlier.
One final thing: If you want to keep tabs on Meredith movements, and for more analysis on the company, make sure you add it to your Watchlist.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.